Evoke Pharma (NASDAQ:EVOK) Share Price Crosses Below Two Hundred Day Moving Average of $0.87

Evoke Pharma, Inc. (NASDAQ:EVOK) shares crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.87 and traded as low as $0.41. Evoke Pharma shares last traded at $0.49, with a volume of 10,780 shares traded.

Analyst Upgrades and Downgrades

Separately, StockNews.com started coverage on shares of Evoke Pharma in a research report on Saturday. They issued a “sell” rating for the company.

Evoke Pharma Trading Up 6.1 %

The stock’s 50-day simple moving average is $0.57 and its 200-day simple moving average is $0.87. The stock has a market cap of $4.12 million, a price-to-earnings ratio of -0.21 and a beta of 0.38.

Evoke Pharma (NASDAQ:EVOK) last issued its quarterly earnings results on Thursday, March 14th. The specialty pharmaceutical company reported ($0.59) earnings per share (EPS) for the quarter. Evoke Pharma had a negative net margin of 150.43% and a negative return on equity of 517.99%. The company had revenue of $1.68 million during the quarter.

Evoke Pharma Company Profile

Evoke Pharma, Inc, a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults.